These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 18625200)

  • 1. Reversal of new-onset type 1 diabetes in mice by syngeneic bone marrow transplantation.
    Wen Y; Ouyang J; Yang R; Chen J; Liu Y; Zhou X; Burt RK
    Biochem Biophys Res Commun; 2008 Sep; 374(2):282-7. PubMed ID: 18625200
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Time point is important for effects of syngeneic bone marrow transplantation for type 1 diabetes in mice.
    Wen Y; Ouyang J; Li W; Chen J; Liu Y; Meng L; Zhang H; Zhou X
    Transplant Proc; 2009 Jun; 41(5):1801-7. PubMed ID: 19545732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islets induce CD4(+) [corrected] CD25(-)Foxp3(+) [corrected] T-cell regulated tolerance to HY-mismatched skin grafts.
    Yoon IH; Choi SE; Kim YH; Yang SH; Park JH; Park CS; Kim Y; Kim JS; Kim SJ; Simpson E; Park CG
    Transplantation; 2008 Nov; 86(10):1352-60. PubMed ID: 19034003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune changes in type 1 diabetes animal model after syngeneic bone marrow transplantation].
    Lü CL; Ouyang J
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Jun; 18(3):726-30. PubMed ID: 20561438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Upregulating CD4+CD25+FOXP3+ regulatory T cells in pancreatic lymph nodes in diabetic NOD mice by adjuvant immunotherapy.
    Tian B; Hao J; Zhang Y; Tian L; Yi H; O'Brien TD; Sutherland DE; Hering BJ; Guo Z
    Transplantation; 2009 Jan; 87(2):198-206. PubMed ID: 19155973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive effects of syngeneic bone marrow transplantation on diabetic nephropathy in mice.
    Ouyang J; Hu G; Wen Y; Zhang X
    Transpl Immunol; 2010 Feb; 22(3-4):184-90. PubMed ID: 20045460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of an autoimmune encephalomyelitis mouse model with nonmyeloablative conditioning and syngeneic bone marrow transplantation.
    Meng L; Ouyang J; Zhang H; Wen Y; Chen J; Zhou J
    Restor Neurol Neurosci; 2011; 29(3):177-85. PubMed ID: 21586824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous bone marrow-derived rat mesenchymal stem cells promote PDX-1 and insulin expression in the islets, alter T cell cytokine pattern and preserve regulatory T cells in the periphery and induce sustained normoglycemia.
    Boumaza I; Srinivasan S; Witt WT; Feghali-Bostwick C; Dai Y; Garcia-Ocana A; Feili-Hariri M
    J Autoimmun; 2009 Feb; 32(1):33-42. PubMed ID: 19062254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combinatorial Treatment of Bone Marrow Transplantation and Regulatory T Cells Improves Glycemia in Streptozotocin-diabetic Mice.
    Min H; Ding J; Wen Y; Ma X; Gao Q
    Exp Clin Endocrinol Diabetes; 2015 Nov; 123(10):638-44. PubMed ID: 26625334
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse foxp3 expression in children with type 1 diabetes and celiac disease.
    Kivling A; Nilsson L; Fälth-Magnusson K; Söllvander S; Johanson C; Faresjö M
    Ann N Y Acad Sci; 2008 Dec; 1150():273-7. PubMed ID: 19120312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bone marrow-derived stem cells initiate pancreatic regeneration.
    Hess D; Li L; Martin M; Sakano S; Hill D; Strutt B; Thyssen S; Gray DA; Bhatia M
    Nat Biotechnol; 2003 Jul; 21(7):763-70. PubMed ID: 12819790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined insulin B:9-23 self-peptide and polyinosinic-polycytidylic acid accelerate insulitis but inhibit development of diabetes by increasing the proportion of CD4+Foxp3+ regulatory T cells in the islets in non-obese diabetic mice.
    Fukushima K; Abiru N; Nagayama Y; Kobayashi M; Satoh T; Nakahara M; Kawasaki E; Yamasaki H; Ueha S; Matsushima K; Liu E; Eguchi K
    Biochem Biophys Res Commun; 2008 Mar; 367(4):719-24. PubMed ID: 18194666
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low levels of allogeneic but not syngeneic hematopoietic chimerism reverse autoimmune insulitis in prediabetic NOD mice.
    Kaminitz A; Mizrahi K; Yaniv I; Farkas DL; Stein J; Askenasy N
    J Autoimmun; 2009 Sep; 33(2):83-91. PubMed ID: 19632089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of experimental diabetes by multiple bone marrow transplantation.
    Banerjee M; Kumar A; Bhonde RR
    Biochem Biophys Res Commun; 2005 Mar; 328(1):318-25. PubMed ID: 15670786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New type of human blood stem cell: a double-edged sword for the treatment of type 1 diabetes.
    Zhao Y; Lin B; Dingeldein M; Guo C; Hwang D; Holterman MJ
    Transl Res; 2010 May; 155(5):211-6. PubMed ID: 20403575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bone marrow or foetal liver cells fail to induce islet regeneration in diabetic Akita mice.
    Akashi T; Shigematsu H; Hamamoto Y; Iwasaki H; Yatoh S; Bonner-Weir S; Akashi K; Weir GC
    Diabetes Metab Res Rev; 2008 Oct; 24(7):585-90. PubMed ID: 18727153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased FOXP3 expression in small-bowel mucosa of children with coeliac disease and type I diabetes mellitus.
    Vorobjova T; Uibo O; Heilman K; Rägo T; Honkanen J; Vaarala O; Tillmann V; Ojakivi I; Uibo R
    Scand J Gastroenterol; 2009; 44(4):422-30. PubMed ID: 19096978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of CD4+CD25+Foxp3+ regulatory T cell response by glatiramer acetate in type 1 diabetes.
    Cui G; Zhang Y; Gong Z; Zhang JZ; Zang YQ
    Cell Res; 2009 May; 19(5):574-83. PubMed ID: 19188932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.